Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01809652 · ClinicalTrials.gov registry record · NA
Feasibility Study of Remote Support for Implantable Pulse Generator (IPG)/Implantable Cardioverter Defibrillator (ICD) Implant
A NA study of Bradycardia and Sudden Cardiac Arrest, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 1
- Study location
NCT01809652: Completed NA study of Bradycardia and Sudden Cardiac Arrest, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
NCT01809652 is a NA study of Bradycardia and Sudden Cardiac Arrest that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 37 participants, below the 4,411-participant average among 29 other Bradycardia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01809652, a NA study of Bradycardia and Sudden Cardiac Arrest, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to gain real world, live implant experience with the remote implant support system. This system is intended to provide the technical support for device implants from a remote location through telepresence (audio and video) and remote control. Specifically, the goals of this study are to corroborate bench testing, assess the performance of the system, gain understanding of the workflows, customer experience, and logistics. The intent of the remote support model is to provide the same support that would typically be provided by a local support person, only remotely. As such, the remote support person would only perform actions that a local support person would routinely do under the direction of a physician. This may involve observing patient data, providing technical support and advice, and performing testing and device reprogramming via remote control of the programmer.
Primary Outcome
Percentage of patients whose implantable devices with clinically equivalent programming by remote support and local support.
Conditions Studied
Interventions
- OTHER Remote Implant Support Capability
Study Locations (1)
Tennessee
- Centennial Heart - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2013-12 |
| Est. Completion | 2014-04 |
| Phase | NA |
What the finished NCT01809652 record still lists
NCT01809652 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 4,411-participant average among 29 other Bradycardia trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Bradycardia appearing as the primary indexed condition, and to 1 intervention - of which Remote Implant Support Capability is the first listed.
NCT01809652 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT01809652 about?
NCT01809652 is a clinical study titled "Feasibility Study of Remote Support for Implantable Pulse Generator (IPG)/Implantable Cardioverter Defibrillator (ICD) Implant". The purpose of this study is to gain real world, live implant experience with the remote implant support system. This system is intended to provide the technical support for device implants from a remote location through telepresence (audio and video) and remote control. Specifically, the goals of t...
What is the current status of trial NCT01809652?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2013-12. Estimated completion is 2014-04.
What conditions does trial NCT01809652 study?
This clinical trial studies the following conditions: Bradycardia, Sudden Cardiac Arrest.
What interventions are being tested in trial NCT01809652?
The interventions under investigation include: Remote Implant Support Capability (OTHER).
Who is sponsoring clinical trial NCT01809652?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01809652 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bradycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01809652's enrollment target sits among peer trials
37 27th of 29 higher than 3 of 29 other Bradycardia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bradycardia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
RECRUITING · NA
-
Augmented Pacing for Shock in the Cardiac Intensive Care Unit
RECRUITING · NA
-
BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S
ACTIVE NOT RECRUITING · NA
-
Aveir DR i2i Study
ACTIVE NOT RECRUITING · NA
-
The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System
ACTIVE NOT RECRUITING · NA
-
EMRI SureScan™ Clinical Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia